Inclusion Compound Based Approach to Arrays of Artificial Dipolar Molecular Rotors: Bulk Inclusions von Kobr, Lukáš, Zhao, Ke, Shen, Yongqiang, Polívková, Kateřina, Shoemaker, Richard K, Clark, Noel A, Price, John C, Rogers, Charles T, Michl, Josef

Volltext

Unexpected behaviour of monospirothiacalix[4]arene under acidic conditions von Polívková, Kateřina, Šimánová, Markéta, Budka, Jan, Cuřínová, Petra, Císařová, Ivana, Lhoták, Pavel

Volltext

Does leaf gas exchange correlate with petiole xylem structural traits in Ulmus laevis seedlings under well-watered and drought stress conditions? von Gebauer, Roman, Urban, Josef, Volařík, Daniel, Matoušková, Marie, Vitásek, Roman, Houšková, Kateřina, Hurt, Václav, Pantová, Petra, Polívková, Terezie, Plichta, Roman

Volltext

Nanostructured silver coatings on polyimide and their antibacterial response von Siegel, Jakub, Polívková, Markéta, Staszek, Marek, Kolářová, Kateřina, Rimpelová, Silvie, Švorčík, Václav

Volltext

Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells von Polivkova, Vaclava, Benesova, Adela, Zizkova, Hana, Koblihova, Jitka, Curik, Nikola, Motlova, Eliska, Klamova, Hana, Salek, Cyril, Machova Polakova, Katerina

Volltext

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission von Machova Polakova, Katerina, Zizkova, Hana, Zuna, Jan, Motlova, Eliska, Hovorkova, Lenka, Gottschalk, Andrea, Glauche, Ingmar, Koblihova, Jitka, Pecherkova, Pavla, Klamova, Hana, Stastna Markova, Marketa, Srbova, Dana, Benesova, Adela, Polivkova, Vaclava, Jurcek, Tomas, Zackova, Daniela, Mayer, Jiri, Ernst, Thomas, Mahon, Francois X., Saussele, Susanne, Roeder, Ingo, Cross, Nicholas C. P., Hochhaus, Andreas

Volltext

Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations von Curik, Nikola, Laznicka, Adam, Polivkova, Vaclava, Krizkova, Jitka, Pokorna, Eva, Semerak, Pavel, Suchankova, Pavla, Burda, Pavel, Hochhaus, Andreas, Machova Polakova, Katerina

Volltext

S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL von Čuřík, Nikola, Laznicka, Adam, Polivkova, Vaclava, Křížková, Jitka, Semerak, Pavel, Pokorna, Eva, Suchankova, Pavla, Burda, Pavel, Hochhaus, Andreas, Machová Poláková, Kateřina

Volltext

Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events von Burda, Pavel, Hlavackova, Alzbeta, Polivkova, Vendula, Curik, Nikola, Laznicka, Adam, Krizkova, Jitka, Suttnar, Jiri, Klener, Pavel, Polakova, Katerina Machova

Volltext

Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients von Hovorkova, Lenka, Winkowska, Lucie, Skorepova, Justina, Krumbholz, Manuela, Benesova, Adela, Polivkova, Vaclava, Alten, Julia, Bardini, Michela, Meyer, Claus, Kim, Rathana, Trahair, Toby N, Clappier, Emmanuelle, Chiaretti, Sabina, Henderson, Michelle, Sutton, Rosemary, Sramkova, Lucie, Stary, Jan, Polakova, Katerina Machova, Marschalek, Rolf, Metzler, Markus, Cazzaniga, Giovanni, Cario, Gunnar, Trka, Jan, Zaliova, Marketa, Zuna, Jan

Volltext

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in Hi... von Polivkova, Vaclava, Rohon, Peter, Klamova, Hana, Cerna, Olga, Divoka, Martina, Curik, Nikola, Zach, Jan, Novak, Martin, Marinov, Iuri, Soverini, Simona, Faber, Edgar, Machova Polakova, Katerina

Volltext

The Rate of Cellular Energy Production of Muscle Cells Is Attenuated By Carnitine Intracellular Deficiency Caused By Imatinib Treatment von Burda, Pavel, Hlavackova, Alzbeta, Polivkova, Vaclava, Curik, Nikola, Klamová, Hana, Koblihova, Jitka, Suttnar, Jiri, Machova, Katerina

Volltext

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining von Curik, Nikola, Polivkova, Vaclava, Burda, Pavel, Koblihova, Jitka, Laznicka, Adam, Kalina, Tomas, Kanderova, Veronika, Brezinova, Jana, Ransdorfova, Sarka, Karasova, Dominika, Rejlova, Katerina, Bakardjieva, Marina, Kuzilkova, Daniela, Kundrat, David, Linhartova, Jana, Klamova, Hana, Salek, Cyril, Klener, Pavel, Hrusak, Ondrej, Machova Polakova, Katerina

Volltext

Exosomes released by imatinib‑resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib‑sensitive cells in the presence o... von Hrdinova, Tereza, Toman, Ondrej, Dresler, Jiri, Klimentova, Jana, Salovska, Barbora, Pajer, Petr, Bartos, Oldrich, Polivkova, Vaclava, Linhartova, Jana, Polakova, Katerina Machova, Kabickova, Hana, Brodska, Barbora, Krijt, Matyas, Zivny, Jan, Vyoral, Daniel, Petrak, Jiri

Volltext

Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes von Vymetalkova, Veronika, Soucek, Pavel, Kunicka, Tereza, Jiraskova, Katerina, Brynychova, Veronika, Pardini, Barbara, Novosadova, Vendula, Polivkova, Zdena, Kubackova, Katerina, Kozevnikovova, Renata, Ambrus, Miloslav, Vodickova, Ludmila, Naccarati, Alessio, Vodicka, Pavel

Volltext

Unstable major molecular response as a trigger for next generation sequencing‐based BCR::ABL1 mutation testing in chronic myeloid leukemia von Benesova, Adela, De Santis, Sara, Polivkova, Vaclava, Pecherkova, Pavla, Krizkova, Jitka, Suchankova, Pavla, Monaldi, Cecilia, Klamova, Hana, Srbova, Dana, Zizkova, Hana, Hochhaus, Andreas, Soverini, Simona, Machova Polakova, Katerina

Volltext

The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib von Machova Polakova, Katerina, Albeer, Ali, Polivkova, Vaclava, Krutska, Monika, Vlcanova, Katerina, Curik, Nikola, Fabarius, Alice, Klamova, Hana, Spiess, Birgit, Waller, Cornelius F., Brümmendorf, Tim H., Dengler, Jolanta, Kunzmann, Volker, Burchert, Andreas, Belohlavkova, Petra, Mustjoki, Satu, Faber, Edgar, Mayer, Jiri, Zackova, Daniela, Panayiotidis, Panayiotis, Richter, Johan, Hjorth-Hansen, Henrik, Kamińska, Magdalena, Płonka, Magdalena, Szczepanek, Elżbieta, Szarejko, Monika, Bober, Grażyna, Hus, Iwona, Grzybowska-Izydorczyk, Olga, Wasilewska, Ewa, Paczkowska, Edyta, Niesiobędzka-Krężel, Joanna, Giannopoulos, Krzysztof, Mahon, Francois X., Sacha, Tomasz, Saußele, Susanne, Pfirrmann, Markus

Volltext

Constant BCR-ABL transcript level ≥0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis von Poláková, Kateřina Machová, Polívková, Václava, Rulcová, Jana, Klamová, Hana, Jurček, Tomáš, Dvořáková, Dana, Žáčková, Daniela, Pospíšil, Zdeněk, Mayer, Jiří, Moravcová, Jana

Volltext

Somatic Mutations in Cancer-Related Genes Were Observed More Frequently in AYA CML Patients Compared to Elderly at Diagnosis, Whereas the Frequency Was Markedly Higher in Elderly P... von Krizkova, Jitka, Polivkova, Vaclava, Curik, Nikola, Laznicka, Adam, Benesova, Adela, Klamova, Hana, Stastna Markova, Marketa, Srbova, Dana, Zuna, Jan, Zaliova, Marketa, Trka, Jan, Semerak, Pavel, Kalina, Tomas, Salek, Cyril, Machova Polakova, Katerina

Volltext

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment von Jaruskova, Monika, Curik, Nikola, Hercog, Rajna, Polivkova, Vaclava, Motlova, Eliska, Benes, Vladimir, Klamova, Hana, Pecherkova, Pavla, Belohlavkova, Petra, Vrbacky, Filip, Machova Polakova, Katerina

Volltext